These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
392 related articles for article (PubMed ID: 27717206)
21. miR-200c: a versatile watchdog in cancer progression, EMT, and drug resistance. Mutlu M; Raza U; Saatci Ö; Eyüpoğlu E; Yurdusev E; Şahin Ö J Mol Med (Berl); 2016 Jun; 94(6):629-44. PubMed ID: 27094812 [TBL] [Abstract][Full Text] [Related]
22. Heterogeneous expression of zinc-finger E-box-binding homeobox 1 plays a pivotal role in metastasis via regulation of miR-200c in epithelial-mesenchymal transition. Muto Y; Suzuki K; Kato T; Tsujinaka S; Ichida K; Takayama Y; Fukui T; Kakizawa N; Watanabe F; Saito M; Futsuhara K; Noda H; Miyakura Y; Konishi F; Rikiyama T Int J Oncol; 2016 Sep; 49(3):1057-67. PubMed ID: 27315529 [TBL] [Abstract][Full Text] [Related]
23. MicroRNA-200c Inhibits the Metastasis of Triple-Negative Breast Cancer by Targeting ZEB2, an Epithelial-Mesenchymal Transition Regulator. Chen H; Li Z; Zhang L; Zhang L; Zhang Y; Wang Y; Xu M; Zhong Q Ann Clin Lab Sci; 2020 Jul; 50(4):519-527. PubMed ID: 32826250 [TBL] [Abstract][Full Text] [Related]
24. MicroRNA-409-3p regulates cell invasion and metastasis by targeting ZEB1 in breast cancer. Ma Z; Li Y; Xu J; Ren Q; Yao J; Tian X IUBMB Life; 2016 May; 68(5):394-402. PubMed ID: 27079864 [TBL] [Abstract][Full Text] [Related]
25. A novel long non-coding RNA linc-ZNF469-3 promotes lung metastasis through miR-574-5p-ZEB1 axis in triple negative breast cancer. Wang PS; Chou CH; Lin CH; Yao YC; Cheng HC; Li HY; Chuang YC; Yang CN; Ger LP; Chen YC; Lin FC; Shen TL; Hsiao M; Lu PJ Oncogene; 2018 Aug; 37(34):4662-4678. PubMed ID: 29755127 [TBL] [Abstract][Full Text] [Related]
26. Proteasome inhibitor-resistant cells cause EMT-induction via suppression of E-cadherin by miR-200 and ZEB1. Asakura T; Yamaguchi N; Ohkawa K; Yoshida K Int J Oncol; 2015 May; 46(5):2251-60. PubMed ID: 25738863 [TBL] [Abstract][Full Text] [Related]
27. MiR-429 is linked to metastasis and poor prognosis in renal cell carcinoma by affecting epithelial-mesenchymal transition. Machackova T; Mlcochova H; Stanik M; Dolezel J; Fedorko M; Pacik D; Poprach A; Svoboda M; Slaby O Tumour Biol; 2016 Nov; 37(11):14653-14658. PubMed ID: 27619681 [TBL] [Abstract][Full Text] [Related]
28. miR-200c enhances sensitivity of drug-resistant non-small cell lung cancer to gefitinib by suppression of PI3K/Akt signaling pathway and inhibites cell migration via targeting ZEB1. Zhou G; Zhang F; Guo Y; Huang J; Xie Y; Yue S; Chen M; Jiang H; Li M Biomed Pharmacother; 2017 Jan; 85():113-119. PubMed ID: 27930974 [TBL] [Abstract][Full Text] [Related]
29. 53BP1 suppresses epithelial-mesenchymal transition by downregulating ZEB1 through microRNA-200b/429 in breast cancer. Kong X; Ding X; Li X; Gao S; Yang Q Cancer Sci; 2015 Aug; 106(8):982-9. PubMed ID: 26011542 [TBL] [Abstract][Full Text] [Related]
30. Prognostic value of microRNA-9 and microRNA-155 expression in triple-negative breast cancer. Jang MH; Kim HJ; Gwak JM; Chung YR; Park SY Hum Pathol; 2017 Oct; 68():69-78. PubMed ID: 28882698 [TBL] [Abstract][Full Text] [Related]
31. Evaluating the role of hsa-miR-200c in reversing the epithelial to mesenchymal transition in prostate cancer. Basu S; Chaudhary A; Chowdhury P; Karmakar D; Basu K; Karmakar D; Chatterjee J; Sengupta S Gene; 2020 Mar; 730():144264. PubMed ID: 31759982 [TBL] [Abstract][Full Text] [Related]
32. Genetic dissection of the miR-200-Zeb1 axis reveals its importance in tumor differentiation and invasion. Title AC; Hong SJ; Pires ND; Hasenöhrl L; Godbersen S; Stokar-Regenscheit N; Bartel DP; Stoffel M Nat Commun; 2018 Nov; 9(1):4671. PubMed ID: 30405106 [TBL] [Abstract][Full Text] [Related]
33. Tamoxifen reverses epithelial-mesenchymal transition by demethylating miR-200c in triple-negative breast cancer cells. Wang Q; Cheng Y; Wang Y; Fan Y; Li C; Zhang Y; Wang Y; Dong Q; Ma Y; Teng YE; Qu X; Liu Y BMC Cancer; 2017 Jul; 17(1):492. PubMed ID: 28724364 [TBL] [Abstract][Full Text] [Related]
34. Tumor-suppressive microRNA-34a inhibits breast cancer cell migration and invasion via targeting oncogenic TPD52. Li G; Yao L; Zhang J; Li X; Dang S; Zeng K; Zhou Y; Gao F Tumour Biol; 2016 Jun; 37(6):7481-91. PubMed ID: 26678891 [TBL] [Abstract][Full Text] [Related]
35. Phosphodiesterase 7B/microRNA-200c relationship regulates triple-negative breast cancer cell growth. Zhang DD; Li Y; Xu Y; Kim J; Huang S Oncogene; 2019 Feb; 38(7):1106-1120. PubMed ID: 30209363 [TBL] [Abstract][Full Text] [Related]
36. miR-340 and ZEB1 negative feedback loop regulates TGF-β- mediated breast cancer progression. Hou LK; Yu Y; Xie YG; Wang J; Mao JF; Zhang B; Wang X; Cao XC Oncotarget; 2016 May; 7(18):26016-26. PubMed ID: 27036021 [TBL] [Abstract][Full Text] [Related]
37. microRNA-200c/141 upregulates SerpinB2 to promote breast cancer cell metastasis and reduce patient survival. Jin T; Suk Kim H; Ki Choi S; Hye Hwang E; Woo J; Suk Ryu H; Kim K; Moon A; Kyung Moon W Oncotarget; 2017 May; 8(20):32769-32782. PubMed ID: 28427146 [TBL] [Abstract][Full Text] [Related]
38. MiR-652 inhibits acidic microenvironment-induced epithelial-mesenchymal transition of pancreatic cancer cells by targeting ZEB1. Deng S; Li X; Niu Y; Zhu S; Jin Y; Deng S; Chen J; Liu Y; He C; Yin T; Yang Z; Tao J; Xiong J; Wu H; Wang C; Zhao G Oncotarget; 2015 Nov; 6(37):39661-75. PubMed ID: 26498682 [TBL] [Abstract][Full Text] [Related]
39. Knockdown of miR-182 promotes apoptosis via regulating RIP1 deubiquitination in TNF-α-treated triple-negative breast cancer cells. Wo L; Lu D; Gu X Tumour Biol; 2016 Oct; 37(10):13733-13742. PubMed ID: 27476169 [TBL] [Abstract][Full Text] [Related]
40. Overexpression of the microRNA hsa-miR-200c leads to reduced expression of transcription factor 8 and increased expression of E-cadherin. Hurteau GJ; Carlson JA; Spivack SD; Brock GJ Cancer Res; 2007 Sep; 67(17):7972-6. PubMed ID: 17804704 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]